dc.contributor.author
Schroeder-Castagno, Maria
dc.contributor.author
Rio-Serrato, Alba Del
dc.contributor.author
Wilhelm, Andreas
dc.contributor.author
Romero-Suárez, Silvina
dc.contributor.author
Schindler, Patrick
dc.contributor.author
Alvarez-González, Cesar
dc.contributor.author
Duchow, Ankelien-Solveig
dc.contributor.author
Bellmann-Strobl, Judith
dc.contributor.author
Ruprecht, Klemens
dc.contributor.author
Hastermann, Maria
dc.contributor.author
Grütz, Gerald
dc.contributor.author
Wildemann, Brigitte
dc.contributor.author
Jarius, Sven
dc.contributor.author
Schmitz-Hübsch, Tanja
dc.contributor.author
Paul, Friedemann
dc.contributor.author
Infante-Duarte, Carmen
dc.date.accessioned
2024-01-11T16:29:04Z
dc.date.available
2024-01-11T16:29:04Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/42009
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-41732
dc.description.abstract
Background: In neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), neutrophils are found in CNS lesions. We previously demonstrated that NMOSD neutrophils show functional deficiencies. Thus, we hypothesized that neutrophil accumulation in the CNS may be facilitated by impairments affecting mechanisms of neutrophil death.
Objective: To evaluate cell death in blood neutrophils from aquaporin-4 (AQP4)-IgG-seropositive NMOSD and MOGAD patients as well as matched healthy controls (HC) using in vitro assays.
Methods: Twenty-eight AQP4 + NMOSD and 19 MOGAD patients in stable disease phase as well as 45 age- and sex-matched HC were prospectively recruited. To induce cell death, isolated neutrophils were cultured with/without phorbol 12-myristate 13-acetate (PMA). Spontaneous and PMA-induced NETosis and apoptosis were analyzed using 7-AAD and annexin-V by flow cytometry. Caspase-3 was assessed by western blot. Myeloperoxidase-DNA complexes (MPO-DNA), MPO and elastase were evaluated by ELISA, and cell-free DNA (cfDNA) by a fluorescence-based assay. Reactive oxygen species (ROS) were evaluated by a dihydrorhodamine 123-based cytometric assay. Serum GM-CSF, IL-6, IL-8, IL-15, TNF-alpha and IL-10 were evaluated by multiplex assays, and neurofilament light chain (NfL) by single-molecule array assay.
Results: In response to PMA, neutrophils from AQP4 + NMOSD but not from MOGAD patients showed an increased survival, and subsequent reduced cell death (29.6% annexin V+ 7-AAD(+)) when compared to HC (44.7%, p = 0.0006). However, AQP4 + NMOSD also showed a mild increase in annexin V+ 7-AAD(-) early apoptotic neutrophils (24.5%) compared to HC (20.8%, p = 0.048). PMA-induced reduction of caspase-3 activation was more pronounced in HC (p = 0.020) than in AQP4 + NMOSD neutrophils (p = 0.052). No differences were observed in neutrophil-derived MPO-DNA or serum levels of MPO, elastase, IL-6, IL-8 and TNF-alpha. IL-15 levels were increased in both groups of patients. In AQP4 + NMOSD, an increase in cfDNA, GM-CSF and IL-10 was found in serum. A positive correlation among cfDNA and NfL was found in AQP4 + NMOSD.
Conclusions: AQP4 + NMOSD neutrophils showed an increased survival capacity in response to PMA when compared to matched HC neutrophils. Although the data indicate that the apoptotic but not the NETotic response is altered in these neutrophils, additional evaluations are required to validate this observation.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Aquaporin-4 NMOSD
en
dc.subject
Neuromyelitis optica spectrum disorders
en
dc.subject
Myelin oligodendrocyte glycoprotein-antibody-associated disease
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
239
dcterms.bibliographicCitation.doi
10.1186/s12974-022-02600-0
dcterms.bibliographicCitation.journaltitle
Journal of Neuroinflammation
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
19
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36183103
dcterms.isPartOf.eissn
1742-2094